Detects Constituents While Excluding Components (e.g., Noise) Patents (Class 600/336)
  • Patent number: 6449501
    Abstract: An improved pulse oximeter is disclosed. The pulse oximeter includes audio signal generation means, controlled by algorithms in a processing element which continuously transform the signals from the sensor into signal quality information. This information is converted into an audio signal and annunciated for the operator's use in guiding sensor placement. This signal quality information is available even in the absence of successful computation of pulse rate and/or oxygen saturation level. It furthermore can reflect signal quality changes that may be too subtle to be reflected in the typical numerical representation of pulse rate and oxygen saturation trend. The audio representation of the signal quality can further be modulated to convey other system and/or physiological status and alerts.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: September 10, 2002
    Assignee: OB Scientific, Inc.
    Inventor: James L. Reuss
  • Patent number: 6442411
    Abstract: The absence of a defined optical pathlength for in vivo measurements creates problems for the noninvasive measurement of analyte concentration. These problems can be reduced by combining measurements made at several wavelengths and using the fact that normal renal function causes the concentration of water in whole blood to be tightly controlled. Hence, the concentration of water in arterial blood can serve as a useful internal standard for such measurements. The measurements are then procured so as to remove the dependency of concentration on path length traversed by the illuminating radiation and on the scattering properties of the volume through which the illuminating radiation propagates. Using this method, one can create improved calibration for measurements of absorbing constituents in arterial blood and thereby provide absolute concentration measurements of constituents such as hemoglobin and glucose in arterial blood.
    Type: Grant
    Filed: April 19, 2000
    Date of Patent: August 27, 2002
    Assignee: Optix, LP
    Inventor: Howard E. Guthermann
  • Patent number: 6434408
    Abstract: A pulse oximetry method and system for improved motion correction is disclosed. The method/system provides for the use of a detector output signal to obtain a different plurality of differential absorption data sets in corresponding relation to each of a succession of measurement, wherein each of the data sets includes differential absorption values for light of a first wavelength and light of a second wavelength. The data sets are processed to obtain a relative motion estimate value for each measurement. When the relative motion estimate value for a given measurement falls within a predetermined range (i.e., corresponding with clinical motion), a corresponding blood analyte indicator value is adjusted in a predetermined manner, wherein the corresponding adjusted blood analyte indicator is employable to obtain at least one blood analyte concentration value. In one embodiment, blood analyte indicator values may be readily multiplied by a predetermined adjustment factor (i.e.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: August 13, 2002
    Assignee: Datex-Ohmeda, Inc.
    Inventor: Donald W. Heckel
  • Patent number: 6430423
    Abstract: A pulse oximeter sensor having an emitter(s) and a detector, with a layer having a first portion of the emitter and a second portion of layer over the detector is provided. A barrier is included between the first and second portions of the overlying layer to substantially block radiation of the wavelengths emitted by the emitter(s). Preferably, the barrier reduces the radiation shunted to less than 10% of the radiation detected, and more preferably to less than 1% of the radiation detected.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: August 6, 2002
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Russ DeLonzor, Paul D. Mannheimer, Michael E. Fein, Don Hannula
  • Publication number: 20020099281
    Abstract: A signal processing method, preferably for extracting a fundamental period from a noisy, low-frequency signal, is disclosed. The signal processing method generally comprises calculating a numerical transform for a number of selected periods by multiplying signal data by discrete points of a sine and a cosine wave of varying period and summing the results. The period of the sine and cosine waves are preferably selected to have a period substantially equivalent to the period of interest when performing the transform.
    Type: Application
    Filed: January 14, 2002
    Publication date: July 25, 2002
    Inventors: Dennis E. Bahr, James L. Reuss.
  • Patent number: 6411833
    Abstract: A method and apparatus for reducing the effects of noise on a system for measuring physiological parameters, such as, for example, a pulse oximeter. The method and apparatus of the invention take into account the physical limitations on various physiological parameters being monitored when weighting and averaging a series of measurements. Varying weights are assigned different measurements, measurements are rejected, and the averaging period is adjusted according to the reliability of the measurements. Similarly, calculated values derived from analyzing the measurements are also assigned varying weights and averaged over adjustable periods. More specifically, a general class of filters such as, for example, Kalman filters, is employed in processing the measurements and calculated values. The filters use mathematical models which describe how the physiological parameters change in time, and how these parameters relate to measurement in a noisy environment.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: June 25, 2002
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Clark R. Baker, Jr., Thomas J. Yorkey
  • Publication number: 20020077536
    Abstract: The present invention involves method and apparatus for analyzing two measured signals that are modeled as containing primary and secondary portions. Coefficients relate the two signals according to a model defined in accordance with the present invention. In one embodiment, the present invention involves utilizing a transformation which evaluates a plurality of possible signal coefficients in order to find appropriate coefficients. Alternatively, the present invention involves using statistical functions or Fourier transform and windowing techniques to determine the coefficients relating to two measured signals. Use of this invention is described in particular detail with respect to blood oximetry measurements.
    Type: Application
    Filed: December 3, 2001
    Publication date: June 20, 2002
    Inventors: Mohamed K. Diab, Esmaiel Kiani-Azarbayjany, Ibrahim M. Elfadel, Rex J. McCarthy, Walter M. Weber, Robert A. Smith
  • Patent number: 6408198
    Abstract: A system is provided for improving photoplethysmographic analyte measurements by de-emphasizing motion-contaminated data and/or emphasizing motion-free data. The system 100 is used in a measurement instrument which includes at least illumination source 104 for transmitting at least two light signals at two center wavelengths through a patient's appendage 106 and a sensor 108 for converting the light signals transmitted through the appendage into electrical output signals. The system 100 includes a first buffer 116 configured to temporarily store at least one pulse cycle of output signals received from the sensor 108. A motion estimator 122 quantifies an amount of motion associated with the output signals stored in the first buffer 116 by performing a principal component analysis on differential absorption values derived from the output signals. Based on the amount of motion estimated, a weight application module 118 is configured to associate a weight with the output signals in the first buffer.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: June 18, 2002
    Assignee: Datex-Ohmeda, Inc.
    Inventors: D. Alan Hanna, Jonas A. Pologe
  • Patent number: 6397092
    Abstract: An oversampling pulse oximeter includes an analog to digital converter with a sampling rate sufficient to take multiple samples per source cycle. In one embodiment, a pulse oximeter (100) includes two mor more light sources (102) driven by light source drives (104) in response to drive signals from a digital signal processing unit (116). The source drives (104) may drive the sources (102) to produce a frequency division multiplex signal. The optical signals transmitted by the light sources (102) are transmitted through a patient's appendage (103) and impinge on a detector (106). The detector (106) provides an analog current signal representative of the received optical signals. An amplifier circuit (110) converts the analog current signal to an analog voltage signal in addition to performing a number of other functions. The amplifier circuit (110) outputs an analog voltage signal which is representative of the optical signals from the sources (102).
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: May 28, 2002
    Assignee: Datex-Ohmeda, Inc.
    Inventors: Mark A. Norris, D. Alan Hanna
  • Patent number: 6393311
    Abstract: A method for removing motion artifacts from devices for sensing bodily parameters and apparatus and system for effecting same. The method includes analyzing segments of measured data representing bodily parameters and possibly noise from motion artifacts. Each segment of measured data may correspond to a single light signal transmitted and detected after transmission or reflection through bodily tissue. Each data segment is frequency analyzed to determine dominant frequency components. The frequency component which represents at least one bodily parameter of interest is selected for further processing. The segment of data is subdivided into subsegments, each subsegment representing one heartbeat. The subsegments are used to calculate a modified average pulse as a candidate output pulse.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: May 21, 2002
    Assignee: NTC Technology Inc.
    Inventors: Reuben W. Edgar, Jr., August J. Allo, Jr., Jesus D. Martin, John R. DelFavero, Michael B. Jaffe
  • Patent number: 6381479
    Abstract: A system for providing an improved DC and low frequency signal rejection in a photoplethysmographic measurement instrument is disclosed. The system is used in a measurement instrument which includes at least two signal sources (106, 108) for transmitting light signals at least at two wavelengths through a tissue of a test subject and a detector (112) for converting light signals transmitted through the tissue into a detector output signal. The system includes a DC restoration (114) which removes DC and low frequency signal components from the detector output signal prior to amplification thereof so as to avoid saturating amplified output signal with the low frequency signal component. The DC restoration (114) is configured to continuously remove low frequency signal component from the detector signal during dark intervals when the signal sources are deactivated, as well as during light intervals when one of the signal sources is activated.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: April 30, 2002
    Assignee: Date-Ohmeda, Inc.
    Inventor: Mark A. Norris
  • Patent number: 6363269
    Abstract: An improved method and apparatus is disclosed for use in frequency division multiplexed spectrophotometric systems. In photoplethysmographic applications the invention provides for the modulation of a plurality of light sources at different frequencies and in accordance with a predetermined phase relationship. Light from the sources that is transmitted through a tissue under test is detected at a detector. A composite signal indicative of the intensity of light received at the detector is demodulated based on the different modulation frequencies and predetermined phase relationship to obtain signal portions corresponding with each of the light sources. Modulation and demodulation are synchronized during each measurement period. The modulation waveforms used to modulate the light sources and corresponding demodulation waveforms used to demultiplex the composite signal are symmetrically timed about a center point for each of the measurement periods.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: March 26, 2002
    Assignee: Datex-Ohmeda, Inc.
    Inventors: D. Alan Hanna, Mark A. Norris
  • Patent number: 6360114
    Abstract: An intelligent, rule-based processor provides signal quality based limits to the signal strength operating region of a pulse oximeter. These limits are superimposed on the typical gain dependent signal strength limits. If a sensor signal appears physiologically generated, the pulse oximeter is allowed to operate with minimal signal strength, maximizing low perfusion performance. If a sensor signal is potentially due to a signal induced by a dislodged sensor, signal strength requirements are raised. Thus, signal quality limitations enhance probe off detection without significantly impacting low perfusion performance. One signal quality measure used is pulse rate density, which defines the percentage of time physiologically acceptable pulses are occurring. If the detected signal contains a significant percentage of unacceptable pulses, the minimum required signal strength is raised proportionately.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: March 19, 2002
    Assignee: Masimo Corporation
    Inventors: Mohamed K. Diab, Ammar Al Ali
  • Patent number: 6360113
    Abstract: The pulse oximeter instrument of the present invention includes switched gain, channel rotation and bootstrap amplification features. In one embodiment, a time-division multiplexed gain circuit is provided in receiver circuitry and is equipped with a switched gain amplifier to faciliate the use of a fixed light source drive and otherwise improve the signal processing characteristics of the instrument. Signal processing is further enhanced via use of a transimpedance amplifier and bootstrap amplifier interconnected across one or more photodiodes. The apparatus time division multiplexes (TDM) the optical input channels to customize the gain response of the apparatus to the variable characteristics of each input channel. Thus, the channel-specific error sources are determined and precisely eliminated from the input data. The channels may also be rotated in subsequent signal conditioning that entails demultiplexing/multiplexing.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: March 19, 2002
    Assignee: Datex-Ohmeda, Inc.
    Inventor: Allen Dettling
  • Patent number: 6339715
    Abstract: A signal processing method, preferably for extracting a fundamental period from a noisy, low-frequency signal, is disclosed. The signal processing method generally comprises calculating a numerical transform for a number of selected periods by multiplying signal data by discrete points of a sine and a cosine wave of varying period and summing the results. The period of the sine and cosine waves are preferably selected to have a period substantially equivalent to the period of interest when performing the transform.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: January 15, 2002
    Assignee: OB Scientific
    Inventors: Dennis E. Bahr, James L. Reuss
  • Publication number: 20010031914
    Abstract: The concentration of glucose in the anterior chamber of an eye is non-invasively measured by guiding a beam through a polarizer (4), a quarter wave plate (6), a polarization modulator (20), and an analyzer (7). After initializing the polarizer and the analyzer to extinguish the beam, it is guided parallel to the iris (56) of the eye (50) and introduced into the anterior chamber (57), wherein it is refracted, impinges on and is reflected from the iris, and exits the anterior chamber approximately collinear with the portion (55A) of the beam incident on the anterior chamber. The beam then is guided onto a detector (10), and a sufficient signal is applied to the polarization modulator to extinguish the beam. The signal represents the glucose concentration in the patient's blood.
    Type: Application
    Filed: June 8, 2001
    Publication date: October 18, 2001
    Applicant: TECMED, INCORPORATED (a New Mexico corporation)
    Inventors: Garth W. Gobeli, Alan J. Leszinske
  • Patent number: 6263221
    Abstract: A spectroscopic system for quantifying in vivo concentration of an absorptive pigment in biological tissue includes an oscillator for generating a first carrier waveform of a first frequency on the order of 108 Hz, a light source for generating light of a selected wavelengths modulated by the carrier waveform, and a detector for detecting radiation that has migrated over photon migration paths in the tissue from an input port to a detection port spaced several centimeters apart. The wavelength is sensitive to concentration of an absorptive pigment present in the tissue. A phase detector compares the detected radiation with the introduced radiation and determines therefrom the phase shift of the detected radiation. A processor quantifies the concentration of the absorptive pigment by calculating a value of the absorption coefficient.
    Type: Grant
    Filed: February 13, 1997
    Date of Patent: July 17, 2001
    Assignee: Non-Invasive Technology
    Inventors: Britton Chance, Vasilis Ntziachristos
  • Patent number: 6263222
    Abstract: A signal processor which acquires a first signal, including a first primary signal portion and a first secondary signal portion, and a second signal, including a second primary signal portion and a second secondary signal portion, wherein the first and second primary signal portions are correlated. The signals may be acquired by propagating energy through a medium and measuring an attenuated signal after transmission or reflection. Alternatively, the signals may be acquired by measuring energy generated by the medium. A processor of the present invention generates a primary or secondary reference signal which is a combination, respectively, of only the primary or secondary signal portions. The secondary reference signal is then used to remove the secondary portion of each of the first and second measured signals via a correlation canceler, such as an adaptive noise canceler, preferably of the joint process estimator type.
    Type: Grant
    Filed: October 6, 1997
    Date of Patent: July 17, 2001
    Assignee: Masimo Corporation
    Inventors: Mohamed K. Diab, Massi E. Kiani, Walter M Weber
  • Patent number: 6246893
    Abstract: The concentration of glucose in the anterior chamber of an eye is non-invasively measured by guiding a beam through a polarizer (4), a quarter wave plate (6), a polarization modulator (20), and an analyzer (7). After initializing the polarizer and the analyzer to extinguish the beam, it is guided parallel to the iris (56) of the eye (50) and introduced into the anterior chamber (57), wherein it is refracted, impinges on and is reflected from the iris, and exits the anterior chamber approximately collinear with the portion (55A) of the beam incident on the anterior chamber. The beam then is guided onto a detector (10), and a sufficient signal is applied to the polarization modulator to extinguish the beam. The signal represents the glucose concentration in the patient's blood.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: June 12, 2001
    Assignee: TecMed Incorporated
    Inventor: Garth W. Gobeli
  • Patent number: 6230035
    Abstract: Irradiating device 3 of a pulse oximeter includes a scattering plate 6. Scattering light is projected into a living tissue. The diameter of the incident area is sufficiently large compared with that of a light receiving area or vice versa. Therefore, tissue terms in a theoretical formula of &PHgr; which represents a ratio of changes of optical densities of tissue measured with two wavelengths are not dependent on the wavelength. The digital processor 10 calculates an oxygen saturation by substituting &PHgr; measured into simultaneous equations.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: May 8, 2001
    Assignee: Nihon Kohden Corporation
    Inventors: Takuo Aoyagi, Masayoshi Fuse, Chen-tai Xie, Michio Kanemoto
  • Patent number: 6192260
    Abstract: Methods and apparatus using the principles of time-resolved spectroscopy are disclosed. The present invention employs incident light pulses of sufficiently short duration to permit the rate of the rise and decay of such pulses to be measured. Consequently, the rate of decay, u, permits a determination of the concentration of an absorptive pigment, such as hemoglobin. The present invention also allows the precise path length the photons travel to be determined. Using this path length information and by measuring changes in optical density using known continuous light (CW) spectrophotometry systems, the methods and apparatus disclosed allow changes in the concentration of an absorptive pigment to be correctly be measured. From these data, the oxygenation state of a tissue region, such as the brain, can be accurately determined in real time.
    Type: Grant
    Filed: April 30, 1992
    Date of Patent: February 20, 2001
    Assignee: Non-Invasive Technology, Inc.
    Inventor: Britton Chance
  • Patent number: 6188470
    Abstract: A Bioenergetic Data Collection Apparatus utilizing a modified oximeter (1) to collect signals characteristic of blood flow in terminal tissue, such as a finger tip (12). A processing means (7) in signal connection with the modified oximeter (1) receives and analyzes the signals to produce pulse waveforms, or a pulse waveform sequence, that is displayed on a high resolution video display (5). An isolation means (8) is provided between the modified oximeter (1) and the processing means (7) to ensure no lethal voltages can threaten a patient. A variety of aids are provided to assist an appropriately skilled practitioner to make a prognosis from the displayed data. The tools include measurement of the ratio of heart activity to heart rest, variation in systolic pulse amplitude, variation in pulse shape, etc.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: February 13, 2001
    Assignee: Larkace Pty Ltd
    Inventor: Robert John Grace
  • Patent number: 6157850
    Abstract: The present invention involves method and apparatus for analyzing two measured signals that are modeled as containing primary and secondary portions. Coefficients relate the two signals according to a model defined in accordance with the present invention. In one embodiment, the present invention involves utilizing a transformation which evaluates a plurality of possible signal coefficients in order to find appropriate coefficients. Alternatively, the present invention involves using statistical functions or Fourier transform and windowing techniques to determine the coefficients relating to two measured signals. Use of this invention is described in particular detail with respect to blood oximetry measurements.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 5, 2000
    Assignee: Masimo Corporation
    Inventors: Mohamed K. Diab, Massi E. Kiani, Ibrahim M. Elfadel, Rex J. McCarthy, Walter M. Weber, Robert A. Smith
  • Patent number: 6151516
    Abstract: A blood constituent monitoring method for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: November 21, 2000
    Assignee: Masimo Laboratories
    Inventors: Esmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper, Jr.
  • Patent number: 6151517
    Abstract: A method and apparatus for performing quantitative noninvasive measurement of blood analytes, includes correction for measurement interference caused by pulse beat and changing body chemistry associated with blood circulation through the part of the body being measured as a function of time. A hypoglycemia monitor and alarm is provided which takes advantage of the methods described for separating pulse beat information from the measurement signals.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: November 21, 2000
    Assignee: Futrex Inc.
    Inventors: David E. Honigs, Robert D. Rosenthal
  • Patent number: 6135952
    Abstract: An adaptive filtering method and apparatus for reducing the level of an undesired noise component in an acquired physiological signal having a desired signal component. The acquired physiological signal is applied to one input of the adaptive filter, and a synthetic reference signal that is modeled so as to exhibit a correlation with the desired signal component is applied to another input of the adaptive filter. Thereafter, in a feedback manner, the adaptive filter iteratively adjusts the modeled synthetic reference signal so as to progressively generate a more accurate approximation of the desired signal component in the adaptive filter, which approximation becomes a reconstruction of the acquired physiological signal wherein the level of the undesired noise component is reduced.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: October 24, 2000
    Assignee: Siemens Corporate Research, Inc.
    Inventor: Frans Martin Coetzee
  • Patent number: 6126612
    Abstract: A method of detecting cyanide concentration in the cutaneously transpired gas of a patient, allowing for the timely implementation of an appropriate treatment. Where the skin of a patient suffering from cyanide poisoning has been burnt, the present invention provides for a noninvasive means of cyanide treatment. In practice, a material is impregnated with methemoglobin and attached to a patient's skin. A barrier means located between the impregnated material and the patient's skin allows for the transfer of cyanide gas from the patient into the material. However, this barrier means does not allow for the transfer of the methemoglobin from the impregnated material into the patient's skin. The material is monitored for photometric change, and, where a change indicative of cyanide poinsoning is present, appropriate treatment is administered.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: October 3, 2000
    Inventors: Michael F. Roizen, Jonathan Moss, Carl Peck
  • Patent number: 6122535
    Abstract: A method of determining at least the concentration of a component from the intensity of electromagnetic waves with at least two selected wavelengths which are reflected by human tissue or transmitted through human tissue comprises firstly the step of converting the intensities of the received electromagnetic signals into at least one first and one second time-dependent electric signal. Then a time-discrete transformation of the first and of the second electric signal into the frequency domain is performed to determine first and second spectral values of the first and of the second signal. Complex combinatorial values are formed from said first and second spectral values and physiologically relevant combinatorial values are selected by evaluating the complex combinatorial values according to given criteria for the physiological relevance thereof. Finally, the concentration of the component is calculated by using the selected combinatorial values or by using the frequencywise-associated spectral values.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: September 19, 2000
    Assignee: Hewlett-Packard Company
    Inventors: Siegfried Kaestle, Hedwig Block, Michael Block
  • Patent number: 6083157
    Abstract: A method of determining the concentration of a component from the intensity of electromagnetic waves with at least two selected wavelengths which are reflected by human tissue or transmitted through human tissue comprises the step of converting first intensities of the received electromagnetic waves into at least one first and one second electric signal. Following this, a continuous first temporal average value of the first signal and a continuous second temporal average value of the second signal are formed. A first alternating component is continuously determined from said first signal and said first average value, whereas a second alternating component is continuously determined from said second signal and said second average value. Subsequently, a continuous ratio is determined from said first and second signals as well as from said first and second continuous temporal average values, with the exception of regions lying close to the zero passages of the alternating components.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: July 4, 2000
    Assignee: Hewlett-Packard Company
    Inventor: Friedemann Noller
  • Patent number: 6081735
    Abstract: The present invention involves method and apparatus for analyzing two measured signals that are modeled as containing primary and secondary portions. Coefficients relate the two signals according to a model defined in accordance with the present invention. In one embodiment, the present invention involves utilizing a transformation which evaluates a plurality of possible signal coefficients in order to find appropriate coefficients. Alternatively, the present invention involves using statistical functions or Fourier transform and windowing techniques to determine the coefficients relating to two measured signals. Use of this invention is described in particular detail with respect to blood oximetry measurements.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: June 27, 2000
    Assignee: Masimo Corporation
    Inventors: Mohamed K. Diab, Massi E. Kiani, Ibrahim M. Elfadel, Rex J. McCarthy, Walter M. Weber, Robert A. Smith
  • Patent number: 6067463
    Abstract: A method and apparatus for measuring the concentration of an analyte of interest, e.g. glucose, in blood non-invasively, i.e., without penetrating the skin or obtaining a biological sample from the body of a patient. The method and apparatus uses a plurality of measurement channels with appropriate wavelengths of interest to control variations of signal and to separate the contribution of the analyte of interest from those of interfering compounds. The method and apparatus of this invention can also be adapted to allow a portion of a body part to be engorged with blood to bring about greater accuracy in optical measurements. In the method of this invention, at least two similar, but not identical, measurements are made concurrently. For example, at least two measurements can be made with similar, but not identical, wavelengths of electromagnetic radiation. The two wavelengths should not be overlapping to allow maximum non-identity.
    Type: Grant
    Filed: January 5, 1999
    Date of Patent: May 23, 2000
    Assignee: Abbott Laboratories
    Inventors: Tzyy-Wen Jeng, Shu-Jen Yeh, John M. Lindberg, Joseph Larry Pezzaniti, Omar S. Khalil, Gary M. Oosta, Charles F. Hanna, Arnold F. Stalder, Ete Z. Szuts
  • Patent number: 6067462
    Abstract: A method and an apparatus to analyze two measured signals that are modeled as containing desired and undesired portions such as noise, FM and AM modulation. Coefficients relate the two signals according to a model defined in accordance with the present invention. In one embodiment, a transformation is used to evaluate a ratio of the two measured signals in order to find appropriate coefficients. The measured signals are then fed into a signal scrubber which uses the coefficients to remove the unwanted portions. The signal scrubbing is performed in either the time domain or in the frequency domain. The method and apparatus are particularly advantageous to blood oximetry and pulserate measurements. In another embodiment, an estimate of the pulserate is obtained by applying a set of rules to a spectral transform of the scrubbed signal. In another embodiment, an estimate of the pulserate is obtained by transforming the scrubbed signal from a first spectral domain into a second spectral domain.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: May 23, 2000
    Assignee: Masimo Corporation
    Inventors: Mohamed K. Diab, Rex McCarthy
  • Patent number: 5995859
    Abstract: A pulse oximeter includes a light-emitting device for repeating red light emission, infrared light emission, and no light emission with respect to an object to be measured every data sampling cycle in a measurement of a saturated oxygen in arterial blood, a light-receiving device for outputting a light-receiving signal obtained by receiving transmitted light or reflected light from the object to be measured; a noise level detecting device for detecting from the light-receiving signal a noise signal level at the time of no light emission in the light-receiving device, and a light-receiving signal generating device for obtaining a light-receiving signal of a level corresponding only to the red light emission and the infrared light emission by subtracting the noise signal level from each of light-receiving signal levels of the red light emission and the infrared light emission.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: November 30, 1999
    Assignee: Nihon Kohden Corporation
    Inventor: Iwao Takahashi
  • Patent number: 5961450
    Abstract: The present invention provides a medical sensor for detecting a blood characteristic. The sensor includes a transducer for producing an analog signal related to the blood characteristic. The analog signal is converted into a transmission signal which is in amplitude-independent form for transmission to a remote analyzer. In one embodiment, a current-to-frequency converter converts a signal from a pulse oximeter sensor into a frequency signal which can be transmitted over a transmission line to a remote pulse oximeter.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: October 5, 1999
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Adnan I. Merchant, Michael Bernstein
  • Patent number: 5954644
    Abstract: An improved photoplethysmographic measurement system is disclosed in which a portion of a time division multiplexed (TDM) signal represents an ambient light level, and other TDM signal portions represent detected levels of two or more centered wavelengths of transmitted light. The ambient and detected light portions of the signal are simultaneously applied to the inputs of an instrumentation amplifier(s) so as to produce a continuous output voltage that is proportional to a difference in voltage between the ambient and detected light portions of a TDM signal. Such an approach provides for ambient light level subtraction with reduced noise and componentry.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: September 21, 1999
    Assignee: Ohmeda Inc.
    Inventors: Allen Dettling, Alan Martin, Kurt Aronow
  • Patent number: 5919134
    Abstract: A method and an apparatus measure blood oxygenation in a subject. A first signal source applies a first input signal during a first time interval. A second signal source applies a second input signal during a second time interval. A detector detects a first parametric signal responsive to the first input signal passing through a portion of the subject having blood therein. The detector also detects a second parametric signal responsive to the second input signal passing through the portion of the subject. The detector generates a detector output signal responsive to the first and second parametric signals. A signal processor receives the detector output signal and demodulates the detector output signal by applying a first demodulation signal to a signal responsive to the detector output signal to generate a first output signal responsive to the first parametric signal.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: July 6, 1999
    Assignee: Masimo Corp.
    Inventor: Mohamed K. Diab
  • Patent number: 5885213
    Abstract: The present invention provides a method and apparatus for adapting to noise sources affecting a pulse oximeter. Various available frequencies are evaluated to determine their respective noise levels and one is selected to act as the operating demultiplexer frequency. During normal operation of the pulse oximeter, the various available demultiplexer frequencies are periodically scanned to determine which has the lowest associated noise. The noise level associated with the operating frequency is used to determine the signal-to-noise ratio of the pulse oximeter signals and thereby qualify certain signals from the pulse oximeter. Those pulses associated with a signal-to-noise ratio below a predetermined threshold are rejected and excluded from use in calculating blood oxygen saturation.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: March 23, 1999
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Charles A. Richardson, Michael Bernstein, Jerry K. Okikawa, Terrence R. Bennett
  • Patent number: 5846190
    Abstract: A pulse oximeter has several processing channels for measurement signals which are measured during the switched-on phase of transmission diodes and which are used to determine the oxygen saturation (SpO.sub.2) of a patient. An additional measurement channel processes an ambient light signal which was measured while the transmission diodes were switched off or their intensity modified, in the same way and thus provides a measure of the spectral composition of the ambient light interference. A useful-to-noise-signal ratio (NSV) is derived from the ambient light signal and a measurement signal, which represents a measure of the signal quality and which can be compared with threshold values (G), where an alarm is triggered if the value falls below the threshold values.
    Type: Grant
    Filed: October 10, 1996
    Date of Patent: December 8, 1998
    Assignee: Hewlett-Packard Company
    Inventor: Dieter Woehrle
  • Patent number: 5820550
    Abstract: An improved pulse oximeter apparatus and method for the measurement of oxygen saturation in the blood, which is faster and more accurate than conventional pulse oximeters. Improved speed and accuracy is attained by elimination of normalization and feedback circuitry and the use of analog to digital converting devices having a wide dynamic range along with a sophisticated computer analysis. The instant invention eliminates inaccuricies resulting from channel matching errors, and detects and eliminates aberrant input data.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: October 13, 1998
    Assignee: Novametrix Medical Systems Inc.
    Inventors: Michael John Ross Polson, Gregory Llewelyn Morris
  • Patent number: 5800348
    Abstract: A method for measuring medical parameters of a patient by radiation of electromagnetic waves into a sample and for measurement and subsequent analysis of the electromagnetic waves which have passed through the sample, the following steps are carried out. First and second modulation signals are generated having equal frequencies and a first phase difference of substantially 90.degree.. Irradiating a first electromagnetic wave of a first wavelength into the sample, under control of the first modulation signal. Irradiating the sample with a second electromagnetic wave of a second wavelength, under control of the second modulation signal.
    Type: Grant
    Filed: September 23, 1996
    Date of Patent: September 1, 1998
    Assignee: Hewlett-Packard Company
    Inventor: Siegfried Kaestle
  • Patent number: 5782756
    Abstract: The present invention utilizes at least three wavelengths of electromagnetic radiation for determining a blood constituent, such as arterial oxygen saturation, in a patient. The detected radiation scattered by the tissue of the patient is analyzed in a manner that compensates for variations in the detected radiation caused by differences in the scattering of the radiation at different wavelengths. In particular, a result is determined which is equivalent to the sum of a first blood constituent estimate using a first pair of the detected signals, and the difference between the first blood constituent estimate and a second blood constituent estimate, using a different pair of wavelengths, with the difference being multiplied by a multiplicative factor.
    Type: Grant
    Filed: September 19, 1996
    Date of Patent: July 21, 1998
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventor: Paul D. Mannheimer
  • Patent number: 5782758
    Abstract: Noise content in the output signal of a system using time division multiplexing (TDM) is measured to determine whether the output signal represents a reliable measurement. A "dark" channel in a TDM input signal may be used to isolate noise which is present in the input signal from desired informational content in the signal. The noise is processed to determine if any component of the noise will be "imaged" into the passband of the system. Any such components are then processed in a manner approximating the system transfer function to produce a noise signal indicative of the noise content of the system output signal. In one embodiment of the invention, the noise signal is used to remove noise from the output signal of the system.
    Type: Grant
    Filed: September 23, 1996
    Date of Patent: July 21, 1998
    Assignee: Ohmeda Inc.
    Inventors: Larry B. Ausec, Richard Frey
  • Patent number: 5772589
    Abstract: This is a method for measuring oxygen saturation of arterial blood in tissue using at least two different wavelengths of light directed into the tissue and measuring the amount of radiation retained by the tissue and compensating the measurements for tissue haemoglobin content and skin pigmentation and pilosity and calibrating the equipment by obtaining measurements after the injection of a medical dye into the tissue.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: June 30, 1998
    Inventor: Peter Bernreuter